A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease (2007-2012)

That Oxpentifylline (Trental) administration will effectively treat erythropoietin or darbepoietin-resistant anaemia in chronic kidney disease patients.